Abstract:Background Left ventricular assist devices (LVADs) are critical for treating advanced heart failure patients. Yet, insights into clinical outcomes, particularly concerning bowel ischemia and mortality, remain scarce. Purpose We aimed to examine temporal trends of in-hospital mortality and bowel ischemia among heart failure patients with LVAD between 2017 and 2020. Methods The National Inpatient Sample was queried from 2017 to 2020 to identify all adults with congestive heart failure who underwent LVAD implantation using the International Classification of Diseases 10th Revision codes. The Cochran-Armitage test was used to assess the linear trend of in-hospital bowel ischemia with LVAD. Multivariable regression analysis was conducted to evaluate the association of LVAD placement with in-hospital mortality and bowel ischemia. The Elixhauser comorbidity index was used to adjust for confounders. Linear logistic results are represented as adjusted odds ratios (ORs) with their respective 95% Confidence Intervals (CIs). Results Of a total of 19,410 LVAD placements, 189 (0.97%) patients developed bowel ischemia of any type. The mean age of these patients was 58 years, with a predominance of males (68%). A trend analysis revealed an increasing occurrence of bowel ischemia following LVAD placement over the years (trend: 1%, p < 0.001). Specifically, the proportion of LVAD patients with bowel ischemia was 0.8% in 2017 (OR = 6, 95% CI 3.6-13, p < 0.001), increased slightly to 0.9% in 2018 (OR = 6.2, 95% CI 3.4-11.7, p < 0.001), followed by a decrease to 0.73% in 2019 (OR = 4.2, 95% CI 2.4-7.5, p = 0.02), and then a rise to 1.53% in 2020 (OR = 7.2, 95% CI 4-12.9, p < 0.001), as illustrated in Figure 1. Across all years, LVAD placement was associated with a significant risk for developing bowel ischemia (OR= 6.9, 95% CI 5-9.6, p < 0.001).The mortality rate among patients who developed bowel ischemia post-LVAD insertion was significant, with a rate of 50% in 2017 (OR = 5.3, 95% CI 1.3-20, p = 0.01), escalating to 67% in 2018 (OR = 10, 95% CI 2.4-43, p < 0.002), and stabilizing at 57% for both 2019 (OR = 8, 95% CI 1.8-37.3, p < 0.006) and 2020 (OR = 6.7, 95% CI 2.3-19.1, p < 0.001), as detailed in Table 1. The overall in-hospital mortality for patients with LVAD and bowel ischemia was 58% (OR = 7, 95% CI 4-14, p < 0.001). Conclusions The study indicates rising trends in-hospital bowel ischemia and fluctuations in mortality rates in LVAD patients from 2017 to 2020. Despite its rarity, LVAD placement carries a notable risk of bowel ischemia, which significantly affects mortality. This underscores the need for vigilant monitoring and management.Figure 1Table 1

Early Stroke Following Durable Left Ventricular Assist Device (LVAD) Implantation: An Analysis of The Society of Thoracic Surgeons Intermacs National Database

Stroke outcomes following durable left ventricular assist device implant in patients bridged with micro‐axial flow pump: Insights from a large registry

Cavitation in Left Ventricular Assist Device Patients: a Potential Early Sign of Pump Thrombosis

Machine Learning Assisted Stroke Prediction in Mechanical Circulatory Support: Predictive Role of Systemic Mitochondrial Dysfunction

Carotid artery structure and hemodynamics and their association with adverse vascular events in left ventricular assist device patients

Sequential Pattern mining of Longitudinal Adverse Events After Left Ventricular Assist Device Implant

Outcomes and Risk Factors for Postoperative Vasoplegia Following Implant of Continuous-Flow Left Ventricular Assist Devices

Left Ventricular Assist Device Implantation Outcomes In Patients With Subcutaneous Implantable Cardioverter-defibrillators: A Case Series

Short- and long-term adverse events in patients on temporary circulatory support before durable ventricular assist device: An IMACS registry analysis

Association of Days Alive and Out of the Hospital After Ventricular Assist Device Implantation With Adverse Events and Quality of Life

Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: Findings from Interagency Registry for Mechanically Assisted Circulatory Support

Electrical storm after left ventricular assist device (LVAD) implantation

Operative strokes after repair of acute type A dissections: predisposing factors and implications

Echocardiographic Predictors of Ventricular Arrhythmias in Patients With Left Ventricular Assist Devices and Implantable Cardioverter‐Defibrillator

Impact of Right Ventricular Dysfunction on Outcomes in Acute Myocardial Infarction and Cardiogenic Shock: Insights from the National Cardiogenic Shock Initiative

Association between psychosocial factors and left ventricular assist device implant outcomes: A systematic review

Comparative analysis of regional outcomes and adverse events after continuous-flow left ventricular assist device implantation: An IMACS analysis

Retrospective Evaluation of Inpatient Warfarin Management Practices in Patients Immediately Following Left Ventricular Assist Device Implantation

Different ECLS Pump Configurations for Temporary Right Ventricular Assist Device in LVAD Patients: A Retrospective Case–Control Study

Left atrial appendage occlusion in ventricular assist device patients to decrease thromboembolic events: A computer simulation study

In-hospital bowel ischemia and mortality trends of left ventricular assist device placement in the USA from 2017 to 2020